0001225208-19-013853.txt : 20191025 0001225208-19-013853.hdr.sgml : 20191025 20191025190711 ACCESSION NUMBER: 0001225208-19-013853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191025 FILED AS OF DATE: 20191025 DATE AS OF CHANGE: 20191025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szyman Catherine M. CENTRAL INDEX KEY: 0001438538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 191170948 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER NAME: FORMER CONFORMED NAME: Szyman Catherine M DATE OF NAME CHANGE: 20080625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2019-10-25 0001099800 Edwards Lifesciences Corp EW 0001438538 Szyman Catherine M. ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Critical Care Common Stock 2019-10-25 4 M 0 2500.0000 66.8600 A 19604.8134 D Common Stock 2019-10-25 4 S 0 2500.0000 227.1900 D 17104.8134 D Employee Stock Option (Right to Acquire) 66.8600 2019-10-25 4 M 0 2500.0000 66.8600 D 2016-02-19 2022-02-18 Common Stock 2500.0000 23570.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2019. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under Issuer's Employee Stock Purchase Plan. Linda J. Park, Attorney-in-Fact 2019-10-25